Max Nowak is an accomplished professional in the field of bioengineering and translational pharmacokinetics/pharmacodynamics, currently serving as a Senior Specialist at Merck since 2024. Previously, as a Senior Scientist at Viridian Therapeutics, Inc., Max expanded modeling capabilities to enhance decision-making in preclinical studies and led projects in the autoimmune and rare disease sectors. At Applied BioMath, contributions involved data analysis and mathematical modeling to support drug development strategies. Max's academic background includes a Ph.D. from Harvard University, where research focused on developing a human microfluidic blood-brain barrier model, alongside earlier positions at UC Santa Barbara and the University of Massachusetts Amherst, culminating in a solid foundation in chemical engineering and biomedicine.
This person is not in any teams
This person is not in any offices